Page 87 - Ipo News Today

Massimo Group (MAMO) plans to raise $6 million in an IPO on Tuesday, February 13th, IPO Scoop reports. The company plans to issue 1,300,000 shares at a price of $4.00-$5.00 per share. In the last twelve months, Massimo Group generated $99 million in revenue and $7.5 million in net income. Roth Capital Partners and Craft […]

Under the scheme, Ola Electric is eligible for incentives for up to five consecutive financial years, commencing in fiscal 2023-24.

Hyundai Motor has appointed investment bankers JPMorgan and Citi to advise on its at least $3 billion India IPO, accelerating listing plans in the worlds third-largest auto market, sources with direct knowledge said.

GJNX ventures backed by Gunavanthkumar Vaid, widely known for his preference for SME and small cap companies, features in the list of investors with 1.80 percent shareholding in the company at the time of filing the draft red herring prospectus.

Telomir Pharmaceuticals Inc., a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, is developing Telomir-1 as the first novel small molecule, to lengthen the DNA's protective telomere caps in order to affect age reversal, said that it has priced its initial public offering of 1 million shares of its common stock at $7.

The rebound in palm oil prices is likely to be capped by abundant supplies of rival soy oil and sunflower oil.

Genetic medicines company Metagenomi Technologies said on Thursday it is aiming for a valuation of $563 million in its US initial public offering (IPO.

In 2023, the Indian arm of the investment bank worked on deals like the blockbuster $365-million Tata Technologies IPO, the $630-million Cube Highways InvIT listing and the $280-million Brookfield India REIT QIP

Biggest mining IPO for more than a year completes bookbuild in record time

Genetic medicines company Metagenomi Technologies plans to raise about $93.8-million in U.S. initial public offering